Headline
The latest stories from AHA Today.
Hospitals continue to experience the same challenges that made 2022 the worst financial year since the start of the COVID-19 pandemic, including higher labor expenses and lower patient volumes, according to the latest report on hospital finances from Kaufman Hall. Hospital operating margins fell…
The Food and Drug Administration Friday authorized for emergency use the first over-the-counter test to detect both flu and SARS-CoV-2, the virus that causes COVID-19. The Lucira COVID-19 & Flu Home Test provides results from self-collected nasal swab samples in about 30 minutes.
The Centers for Medicare & Medicaid Services Friday proposed changing how it calculates the Medicaid fraction for Medicare Disproportionate Share Hospital payments.
The Drug Enforcement Administration Friday proposed limiting telehealth prescriptions for buprenorphine and other controlled substances after the COVID-19 public health emergency to a 30-day supply unless the prescriber or referring clinician have evaluated the patient in person. DEA will accept…
Effective Feb. 27, certified independent dispute resolution entities will resume issuing payment determinations for payment disputes involving out-of-network services and items furnished before Oct. 25, 2022, the Centers for Medicare & Medicaid Services announced.
The Centers for Disease Control and Prevention today advised clinicians to report extensively drug-resistant strains of Shigella infections to their state or local health department, and educate patients and communities at increased risk.
“There are three things America’s hospitals have in common right now: sicker patients, a smaller workforce and higher labor and supply costs,” writes AHA President and CEO Rick Pollack in an op-ed today in Real Clear Health.
AHA has elected Ascension CEO Joseph R. Impicciche to immediately fill a vacancy on its Board of Trustees effective through 2024.
AHA’s United Against the Flu campaign today released a new social media toolkit to help hospitals and health systems encourage their communities to get vaccinated against the flu and COVID-19, including getting an updated COVID-19 booster.
GE Healthcare expects supplies of its iohexol and iodixanol intraveneous contrast media products for computed tomography imaging to return to normal in the next few weeks.